Why Analysts See The Insulet (PODD) Story Shifting As Omnipod Growth Meets Valuation Questions [Yahoo! Finance]
Insulet Corporation (PODD)
Last insulet corporation earnings: 2/25 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.insulet.com/investor-relations
Company Research
Source: Yahoo! Finance
This kind of fine tuning fits with recent Street research, where most analysts are still focused on Omnipod execution, type 2 diabetes uptake and the long term growth framework, while a smaller group keeps valuation and sector risks front of mind. Stay tuned to see how you can track these subtle but important shifts in the Insulet narrative as new research and company updates come through. Stay updated as the Fair Value for Insulet shifts by adding it to your watchlist or portfolio . Alternatively, explore our Community to discover new perspectives on Insulet. ?? Bullish Takeaways Most recent commentary skews positive, with firms like Goldman Sachs, Truist, BTIG, UBS, Canaccord, Jefferies, Stifel and others keeping Buy ratings while adjusting price targets in a range that broadly brackets the current US$377.72 fair value estimate. Several analysts link their constructive view to execution around Omnipod, citing broad based strength, record new patient starts in both U.S. type
Show less
Read more
Impact Snapshot
Event Time:
PODD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PODD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PODD alerts
High impacting Insulet Corporation news events
Weekly update
A roundup of the hottest topics
PODD
News
- JPM26: Insulet presents optimistic growth plan heading into 2026 [Yahoo! Finance]Yahoo! Finance
- Bernstein Reduces Firm's PT on Insulet (PODD) Stock [Yahoo! Finance]Yahoo! Finance
- Insulet (NASDAQ:PODD) was downgraded by analysts at Barclays PLC from an "overweight" rating to an "equal weight" rating. They now have a $274.00 price target on the stock.MarketBeat
- Insulet to Announce Fourth Quarter and Full Year 2025 Financial Results on February 18, 2026 [Yahoo! Finance]Yahoo! Finance
- Insulet (NASDAQ:PODD) had its "outperform" rating reaffirmed by analysts at Sanford C. Bernstein.MarketBeat
PODD
Earnings
- 11/6/25 - Beat
PODD
Sec Filings
- 1/6/26 - Form 4
- 1/6/26 - Form 4
- 12/19/25 - Form 8-K
- PODD's page on the SEC website